Page last updated: 2024-09-03

2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone and Leukemia L5178

2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone has been researched along with Leukemia L5178 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishimura, T; Sugimoto, Y; Suzuki, H; Tanaka, N; Yamaki, H1

Other Studies

1 other study(ies) available for 2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone and Leukemia L5178

ArticleYear
Mechanism of action of 2-crotonyloxymethyl-4,5,6-trihydroxycyclohex-2-enone, a SH inhibitory antitumor antibiotic, and its effect on drug-resistant neoplastic cells.
    The Journal of antibiotics, 1982, Volume: 35, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; Cyclohexanes; Cyclohexanones; DNA-Directed DNA Polymerase; DNA, Neoplasm; Doxorubicin; Drug Resistance; Leukemia L5178; Leukemia, Experimental; Neoplasm Proteins; Phosphodiesterase Inhibitors; RNA, Neoplasm

1982